HighLife
- Health & Biotech
- Paris, FR
- Founded 2010
- Private
- highlifemedical.com
Paris medtech developing a transfemoral mitral valve replacement system (TMVR) for severe mitral regurgitation.
$90MEquity raised in 2025–20262025 — · 2026 $90M · 1 equity round
$90MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 1 round · 1 source
Earlier rounds not yet sourced. HighLife was founded in 2010 and raised before 22 Sep 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Growth financing (co-led)Amount$90MEUR 80MPost-money—✓ Confirmed
- Earlier rounds not yet sourced
Investors 13
- Andera Partners1
- Mérieux Equity Partners1
- Sofinnova Partners1
- Supernova Invest1
- BNP Paribas Développement
- Capricorn Partners
- Critical Path Ventures
- European Investment Bank
- Pro Benefis Familiae
- Sectoral Asset Management
- SPRIM Global Investments
- USVP
- VI Partners
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
ExeinCyber · $351M in 2025–2026Shared: Supernova Invest, European Investment BankOna TherapeuticsHealth · $86.6M in 2025–2026Shared: Mérieux Equity PartnersTubulisHealth · $401M in 2025–2026Shared: Andera PartnersQuoblyDeep Tech · $133M in 2025–2026Shared: Supernova InvestNeurent MedicalHealth · $74M in 2025–2026Shared: Sofinnova PartnersOrbemDeep Tech · $65.1M in 2025–2026Shared: Supernova Invest
Also in the Paris hub see on the globe
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. HighLife and its logo are trademarks of their owners, used here for identification only.
